US EditionPublished • loading... • Updated
FDA Again Rejects Atara - Los Angeles Business Journal
Summary by labusinessjournal.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
FDA Again Rejects Atara - Los Angeles Business Journal
Executives and investors in Thousand Oaks-based immunotherapy company Atara Biotherapeutics Inc. were left reeling last week after the U.S. Food and Drug Administration unexpectedly rejected the company’s lead drug candidate for the second time in less than a year. The FDA notification came late on Jan. 9. Atara announced the rejection before market open on Jan. 12, sending its shares tumbling 57% over the course of the trading day. The stock pr…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
